CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-12 | Schuth Alexander O. COO and Secretary | Sale | −800 | $19.73 | $16K | 664,289 |
| 2019-02-12 | Schuth Alexander O. COO and Secretary | Sale | −1,700 | $20.24 | $34K | 662,589 |
| 2019-02-11 | Schuth Alexander O. COO and Secretary | Sale | −1,234 | $18.74 | $23K | 666,355 |
| 2019-02-11 | Schuth Alexander O. COO and Secretary | Sale | −1,266 | $19.35 | $24K | 665,089 |
| 2019-02-08 | Schuth Alexander O. COO and Secretary | Sale | −2,500 | $18.11 | $45K | 667,589 |
| 2019-02-08 | Watts Ryan J. President and CEO | Grant or award · Restricted Stock Units | +11,031 | 11,031 | ||
| 2019-02-08 | Watts Ryan J. President and CEO | Grant or award · Restricted Stock Units | +35,200 | 35,200 | ||
| 2019-02-08 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +281,600 | 281,600 | ||
| 2019-02-07 | Schuth Alexander O. COO and Secretary | Grant or award · Restricted Stock Units | +17,000 | 17,000 | ||
| 2019-02-07 | Schuth Alexander O. COO and Secretary | Grant or award · Stock Option (right to buy) | +136,000 | 136,000 | ||
| 2019-02-07 | Ho Carole Chief Medical Officer | Grant or award · Restricted Stock Units | +17,000 | 17,000 | ||
| 2019-02-07 | Ho Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +136,000 | 136,000 | ||
| 2019-02-07 | Krognes Steve E. CFO and Treasurer | Grant or award · Restricted Stock Units | +17,000 | 17,000 | ||
| 2019-02-07 | Krognes Steve E. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +136,000 | 136,000 | ||
| 2019-02-05 | Ho Carole Chief Medical Officer | Option exercise | +7,856 | $5.28 | $41K | 7,856 |
| 2019-02-05 | Ho Carole Chief Medical Officer | Sale | −7,856 | $18.83 | $148K | 0 |
| 2019-02-05 | Ho Carole Chief Medical Officer | Option exercise · Stock Option (right to buy) | −7,856 | 129,630 | ||
| 2019-02-05 | Watts Ryan J. President and CEO | Sale | −8,230 | $18.83 | $155K | 2,634,304 |
| 2019-02-04 | Ho Carole Chief Medical Officer | Option exercise | +730 | $5.28 | $4K | 730 |
| 2019-02-04 | Ho Carole Chief Medical Officer | Option exercise | +3,139 | $5.28 | $17K | 3,869 |
Page 43 of 53 · 1,053 trades